Reuters logo
BRIEF-GlaxoSmithKline receives approval for Benlysta in Japan for treatment of systemic lupus erythematosus
2017年9月27日 / 早上7点18分 / 23 天前

BRIEF-GlaxoSmithKline receives approval for Benlysta in Japan for treatment of systemic lupus erythematosus

Sept 27 (Reuters) - Glaxosmithkline Plc

* ‍JAPANESE MHLW APPROVED BENLYSTA FOR TREATMENT OF ADULT PATIENTS WITH SLE WHO ARE INADEQUATE RESPONDERS TO EXISTING THERAPIES​ Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below